DocGo (NASDAQ:DCGO – Get Free Report) and CochLear (OTCMKTS:CHEOY – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.
Institutional & Insider Ownership
56.4% of DocGo shares are held by institutional investors. 3.8% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares DocGo and CochLear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -56.61% | -34.41% | -23.82% |
| CochLear | N/A | N/A | N/A |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.19 | -$182.40 million | ($1.85) | -0.34 |
| CochLear | $1.53 billion | 5.06 | $251.85 million | N/A | N/A |
CochLear has higher revenue and earnings than DocGo.
Volatility and Risk
DocGo has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, CochLear has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for DocGo and CochLear, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 3 | 3 | 0 | 2.29 |
| CochLear | 0 | 2 | 1 | 2 | 3.00 |
DocGo presently has a consensus price target of $2.38, suggesting a potential upside of 277.52%. Given DocGo’s higher probable upside, equities research analysts clearly believe DocGo is more favorable than CochLear.
Summary
CochLear beats DocGo on 9 of the 13 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
